Company Arrowhead Research Corp Nasdaq
Equities
US0427972098
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Drugs
100.0
%
| 243 | 100.0 % | 241 | 100.0 % | -1.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 243 | 100.0 % | 241 | 100.0 % | -1.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 01/07/01 | |
Director of Finance/CFO | 57 | 01/09/01 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Patrick O'brien
CMP | Compliance Officer | 60 | 01/14/01 |
Bruce Given
COO | Chief Operating Officer | 69 | 26/11/26 |
Vincent Anzalone
IRC | Investor Relations Contact | - | - |
Aaron Tan
AUD | Comptroller/Controller/Auditor | - | 01/21/01 |
Nadia Meshkova
TRE | Treasurer | - | - |
Tracie Oliver
PRN | Corporate Officer/Principal | 62 | 01/22/01 |
Matt Pulisic
PRN | Corporate Officer/Principal | - | 01/20/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 23/10/23 |
Michael Perry
BRD | Director/Board Member | 64 | 19/11/19 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 01/20/01 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01/04 |
Chief Executive Officer | 54 | 01/07/01 | |
William Waddill
BRD | Director/Board Member | 67 | 01/18/01 |
Mauro Ferrari
BRD | Director/Board Member | 64 | 19/10/19 |
Director/Board Member | 60 | 02/22/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 124,200,230 | 118,638,599 ( 95.52 %) | 0 | 95.52 % |
Company contact information
Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard Suite 700
91105, Pasadena
+626 304 3400
http://www.arrowheadpharma.com![address Arrowhead Research Corp](https://cdn.zonebourse.com/static/address/11900128.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+18.37% | 25.93B | |
-24.33% | 19.27B | |
-19.26% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |